Latest Alphabet Inc. Stock Portfolio
Alphabet Inc. Performance:
2025 Q4: 21.89%YTD: 78.73%2024: -7.94%
Performance for 2025 Q4 is 21.89%, and YTD is 78.73%, and 2024 is -7.94%.
About Alphabet Inc. and 13F Hedge Fund Stock Holdings
On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Alphabet Inc. reported an equity portfolio of $2.6 Billions as of 31 Dec, 2025.
The top stock holdings of Alphabet Inc. are ASTS, PL, RVMD. The fund has invested 25.2% of it's portfolio in AST SPACEMOBILE INC and 24.4% of portfolio in PLANET LABS PBC.
The fund managers got completely rid off METSERA INC, FOGHORN THERAPEUTICS INC (FHTX) and TAYSHA GENE THERAPIES INC (TSHA) stocks. They significantly reduced their stock positions in MONTE ROSA THERAPEUTICS INC (GLUE), MAZE THERAPEUTICS INC and REVOLUTION MEDICINES INC (RVMD).
The top stock holdings of Alphabet Inc. are ASTS, PL, RVMD. The fund has invested 25.2% of it's portfolio in AST SPACEMOBILE INC and 24.4% of portfolio in PLANET LABS PBC.
The fund managers got completely rid off METSERA INC, FOGHORN THERAPEUTICS INC (FHTX) and TAYSHA GENE THERAPIES INC (TSHA) stocks. They significantly reduced their stock positions in MONTE ROSA THERAPEUTICS INC (GLUE), MAZE THERAPEUTICS INC and REVOLUTION MEDICINES INC (RVMD).
Alphabet Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Alphabet Inc. made a return of 21.89% in the last quarter. In trailing 12 months, it's portfolio return was 78.73%.
- Performance
- S&P 500
New Buys
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| monte rosa therapeutics inc | -49.12 |
| maze therapeutics inc | -42.44 |
| revolution medicines inc | -19.07 |
Alphabet Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| metsera inc | -197,992,000 |
| barinthus biotherapeutics pl | -1,892,060 |
| tscan therapeutics inc | -1,960,290 |
| fractyl health inc | -1,053,510 |
| taysha gene therapies inc | -2,095,680 |
| foghorn therapeutics inc | -2,449,410 |
| dianthus therapeutics inc | -8,212,230 |
| alector inc | -520,563 |
Alphabet Inc. got rid off the above stocks
Sector Distribution
Alphabet Inc. has about 41.3% of it's holdings in Technology sector.
- Technology
- Industrials
- Others
- Healthcare
| Sector | % |
|---|---|
| Technology | 41.3 |
| Industrials | 24.4 |
| Others | 18.1 |
| Healthcare | 16.1 |
Market Cap. Distribution
Alphabet Inc. has about 38.3% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- LARGE-CAP
- UNALLOCATED
- SMALL-CAP
| Category | % |
|---|---|
| MID-CAP | 41.8 |
| LARGE-CAP | 38.3 |
| UNALLOCATED | 18.1 |
| SMALL-CAP | 1.8 |
Stocks belong to which Index?
About 73.2% of the stocks held by Alphabet Inc. either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
- S&P 500
| Index | % |
|---|---|
| RUSSELL 2000 | 70.5 |
| Others | 26.8 |
| S&P 500 | 2.7 |
Alphabet Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Alphabet Inc.
Alphabet Inc. has 29 stocks in it's portfolio. About 92.8% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. PL was the most profitable stock for Alphabet Inc. last quarter.
Last Reported on: 13 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ALEC | alector inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ASTS | ast spacemobile inc | 25.18 | 8,943,490 | 649,565,000 | unchanged | 0.00 | ||
| AUTL | autolus therapeutics plc | 0.05 | 698,262 | 1,389,540 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 0.35 | 321,604 | 8,914,860 | unchanged | 0.00 | ||
| DXCM | dexcom inc | 2.67 | 1,036,940 | 68,821,500 | unchanged | 0.00 | ||
| EXAS | exact sciences corp | 0.09 | 23,205 | 2,356,700 | unchanged | 0.00 | ||
| FHTX | foghorn therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| FRSH | freshworks inc | 7.70 | 16,206,600 | 198,531,000 | unchanged | 0.00 | ||
| FULC | fulcrum therapeutics inc | 0.01 | 14,262 | 161,303 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics inc | 0.45 | 744,948 | 11,680,800 | reduced | -49.12 | ||
| GTLB | gitlab inc | 3.96 | 2,724,710 | 102,258,000 | unchanged | 0.00 | ||
| HYPR | hyperfine inc | 0.03 | 898,720 | 880,746 | unchanged | 0.00 | ||
| LYEL | lyell immunopharma inc | 0.35 | 293,256 | 9,026,420 | unchanged | 0.00 | ||
| OSCR | oscar health inc | 0.27 | 481,988 | 6,926,170 | unchanged | 0.00 | ||
| PATH | uipath inc | 4.47 | 7,034,340 | 115,293,000 | unchanged | 0.00 | ||
| PL | planet labs pbc | 24.42 | 31,942,600 | 629,909,000 | unchanged | 0.00 | ||
| QNCX | quince therapeutics inc | 0.03 | 189,122 | 633,559 | unchanged | 0.00 | ||
| RGEN | repligen corp | 0.00 | 383 | 62,758 | unchanged | 0.00 | ||
| RLAY | relay therapeutics inc | 0.51 | 1,568,750 | 13,271,700 | unchanged | 0.00 | ||
| RVMD | revolution medicines inc | 10.33 | 3,345,100 | 266,437,000 | reduced | -19.07 | ||